Insider selling at ANI Pharmaceuticals shows routine rebalancing, not a warning—see how a 0.4% sell‑off affects price, sentiment, and long‑term outlook.
Explore how ANI Pharmaceuticals’ insider sales by Cook Meredith reflect a disciplined, rule‑based strategy and what that means for investors and the company’s 2026 growth plan.